Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database

Table 1 Demographic, preoperative, and surgical details for 82 pelvic exenterations n (%)

Variable	Value
Age, yr	61.8 (11.5)
Gender
Male	54 (65.9)
Female	28 (34.1)
ASA score
I	3 (3.7)
II	42 (51.2)
III	33 (40.2)
IV	4 (4.9)
Obstruction	5 (6.1)
MR T
T3	13 (15.9)
T4	56 (68.3)
Missing	13 (15.9)
MR N
N0	11 (13.4)
N1	24 (29.3)
N2	35 (42.7)
Missing	12 (14.6)
Sphincters involved	22 (26.8)
Metastasis at presentation	7 (8.5)
Neoadjuvant treatment	59 (72)
Long course RT	3 (5)
Long course CRT	41 (69.5)
CxT	4 (6.8)
Short Course RT	4 (6.8)
CxT followed by RT	7 (11.9)
Adjuvant treatment	54 (65.9)
CRT	6 (11.1)
CT	48 (88.9)
Perioperative transfusions, n	3.4 (2)
Anastomosis	15 (18.3)
Synchronous metastasis resected	4 (6.8)

Data are expressed as number of patients (%) or median (25-75 percentiles). ASA: American Society of Anaesthesiologists; CRT: Chemoradiation therapy; CxT: Chemotherapy; MR: Magnetic resonance; RT: Radiotherapy.